https://openaifoundation.org/news/update-on-the-openai-foundation
At the Foundation, we’ve identified three initial focus areas where we think this work could make a real difference:
AI for Alzheimer’s: Alzheimer’s is one of the hardest and most heartbreaking diseases families face – and one of the toughest problems in medicine. AI’s ability to reason across complex data could help researchers uncover new insights. We will be partnering with leading research institutions, with an initial focus on mapping disease pathways, detecting biomarkers for clinical care and clinical trials, and accelerating personalization of treatments – including, where possible, repurposing existing FDA-approved molecules.
Public Data for Health: Many of medicine’s biggest advances have been made possible by shared scientific data, and public access to data is essential to deliver the promise of AI for scientific breakthroughs. We will help partners create and expand open, high-quality datasets – and, where appropriate, help responsibly open previously closed ones – so researchers everywhere can leverage AI and use data to drive progress across diseases.
Accelerating Progress on High-Mortality and High-Burden Diseases: We believe AI can help lead to scientific breakthroughs, and lower the cost and risk of developing or repurposing therapies, particularly in high-mortality and high-burden disease areas that are underfunded. We will bring together AI researchers and disease experts, starting with a focused workshop to identify how best to empower scientists with AI tools and surface promising opportunities.
No comments:
Post a Comment